PT  - JOURNAL ARTICLE
AU  - Osborn, Eric A.
AU  - Kessinger, Chase W.
AU  - Tawakol, Ahmed
AU  - Jaffer, Farouc A.
TI  - Metabolic and Molecular Imaging of Atherosclerosis and Venous Thromboembolism
AID  - 10.2967/jnumed.116.182873
DP  - 2017 Jun 01
TA  - Journal of Nuclear Medicine
PG  - 871--877
VI  - 58
IP  - 6
4099  - http://jnm.snmjournals.org/content/58/6/871.short
4100  - http://jnm.snmjournals.org/content/58/6/871.full
SO  - J Nucl Med2017 Jun 01; 58
AB  - Metabolic and molecular imaging continues to advance our understanding of vascular disease pathophysiology. At present, 18F-FDG PET imaging is the most widely used clinical tool for metabolic and molecular imaging of atherosclerosis. However, novel nuclear tracers and intravascular optical near-infrared fluorescence imaging catheters are emerging to assess new biologic targets in vivo and in coronary arteries. This review highlights current metabolic and molecular imaging clinical and near-clinical applications within atherosclerosis and venous thromboembolism, and explores the potential for metabolic and molecular imaging to affect patient-level risk prediction and disease treatment.